This is a preview of subscription content, log in via an institution to check access.
Notes
NPRA = National Pharmaceutical Regulatory Agency; is part of the Ministry of Health Malaysia.
including difficulty breathing, swollen face or tongue, or throat tightness.
Reference
National Pharmaceutical Regulatory Agency, Ministry of Health Malaysia. Guselkumab: Risk of anaphylaxis. Internet Document : 07 Apr 2020. Available from: URL: https://npra.gov.my/index.php/en/component/content/article/419-english/safety-alerts-main/safety-alerts-2020/1527084-guselkumab-risk-of-anaphylaxis.html?Itemid=1391
Rights and permissions
About this article
Cite this article
Malaysia's NPRA advises of anaphylaxis risk with guselkumab. Reactions Weekly 1801, 2 (2020). https://doi.org/10.1007/s40278-020-77662-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-77662-z